Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention.
CONCLUSION: In patients who underwent PCI, polypharmacy at discharge could play a negative role in the adherence to the first refill of EBM. Further studies should investigate other parameters that contribute to long term non-adherence.
PMID: 26517700 [PubMed - as supplied by publisher]
Source: Current Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Mohammed S, Arabi A, El-Menyar A, Abdulkarim S, AlJundi A, Alqahtani A, Arafa S, Al Suwaidi J Tags: Curr Vasc Pharmacol Source Type: research
More News: Angioplasty | Beta-Blockers | Cholesterol | Coronary Angioplasty | Drugs & Pharmacology | Insurance | Men | Middle East Health | Percutaneous Coronary Intervention | Qatar Health | Statin Therapy | Study